Cardiac mitochondria can degrade H2O2 via the glutathione (GSH), thioredoxin (TRX), and catalase pathways (42–44), and, therefore, altered activity of these pathways could explain the difference in ROS production between control and ischemia mitochondria. This evidence concerns the gene TXN and ischemia.